Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2021 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype.
Bos S, Graber AL, Cardona-Ospina JA, Duarte EM, Zambrana JV, Ruíz Salinas JA, Mercado-Hernandez R, Singh T, Katzelnick LC, de Silva A, Kuan G, Balmaseda A, Harris E. Bos S, et al. Among authors: mercado hernandez r. Nat Commun. 2024 Jan 9;15(1):382. doi: 10.1038/s41467-023-44330-8. Nat Commun. 2024. PMID: 38195666 Free PMC article.
Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model.
de Wit E, Feldmann F, Cronin J, Goldin K, Mercado-Hernandez R, Williamson BN, Meade-White K, Okumura A, Callison J, Weatherman S, Rosenke R, Avanzato VA, Lovaglio J, Scott DP, Marzi A, Feldmann H. de Wit E, et al. Among authors: mercado hernandez r. EBioMedicine. 2023 Jan;87:104405. doi: 10.1016/j.ebiom.2022.104405. Epub 2022 Dec 9. EBioMedicine. 2023. PMID: 36508878 Free PMC article.
The association of neutralizing antibodies with protection against symptomatic dengue virus infection varies by serotype, prior infection history, and assay condition.
Bos S, Graber AL, Cardona-Ospina JA, Duarte EM, Zambrana JV, Ruíz Salinas JA, Mercado-Hernandez R, Singh T, Katzelnick LC, de Silva A, Kuan G, Balmaseda A, Harris E. Bos S, et al. Among authors: mercado hernandez r. medRxiv [Preprint]. 2023 Oct 13:2023.06.20.23291522. doi: 10.1101/2023.06.20.23291522. medRxiv. 2023. PMID: 37502957 Free PMC article. Updated. Preprint.